Erick Gamelin

ACRV

Erick Gamelin serves as officer: Chief Development Officer at Acrivon Therapeutics, Inc. Common Stock (ACRV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

11 trades

$24.1K

Net Position

Net Seller

$24.1K

Companies Traded

ACRV

Active Period

Nov 2023 – Aug 2026

11 total trades

Most Recent

Sell ACRV

Aug 20, 2026 · $804.00

Erick Gamelin's Insider Trading at Acrivon Therapeutics, Inc. Common Stock (ACRV)

Buys

0 · $0.00

Sells

11 · $24.1K

Total Shares Bought

Total Shares Sold

5,618

ACRV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 20, 2026	Sell	400	$2.01	$804.00	52,592
Feb 14, 2026	Sell	471	$1.63	$767.73	0
Nov 14, 2025	Sell	403	$2.24	$902.72	0
Aug 14, 2025	Sell	403	$1.39	$560.17	0
May 14, 2025	Sell	403	$1.14	$459.42	0
Feb 14, 2025	Sell	469	$5.42	$2.5K	0
Nov 14, 2024	Sell	402	$7.92	$3.2K	0
Aug 14, 2024	Sell	402	$7.02	$2.8K	0
May 14, 2024	Sell	402	$8.36	$3.4K	0
Feb 14, 2024	Sell	468	$3.40	$1.6K	0
Nov 14, 2023	Sell	1,395	$5.08	$7.1K	0